AbbVie’s $10.9 Billion Apogee Deal Puts a Price on the Next Immunology Race
AbbVie's $10.9 billion deal for Apogee Therapeutics shows how aggressively big pharma is paying to protect its next immunology growth cycle.
Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
AbbVie's $10.9 billion deal for Apogee Therapeutics shows how aggressively big pharma is paying to protect its next immunology growth cycle.
Continuous Coverage
Earth crosses comet 7P/Pons-Winnecke's uneven debris this week. Most years the June Bootids barely show; in 1998 they…
Alberto Carvalho resigned from LAUSD on June 21, leaving acting superintendent AndrĂ©s Chait to stabilize the second-largest U.S.…
Wyndham Clark turned a six-shot final-round cushion into a one-shot survival act at Shinnecock Hills, beating Sam Burns…
A blast at Qatar's Barzan gas facility left 54 injured and 18 missing, exposing how fragile Gulf gas…
Toy Story 5 opened to $160 million in North America for a $312 million global launch, the biggest…
Canada has finalised a A$2.5 billion deal to buy Australia’s over-the-horizon JORN radar for Arctic surveillance — Canberra’s…
Global Affairs
France widened its top heat alert to 49 departments on Monday, June 22, 2026, as schools closed, nights…
Markets And Money
India's consumer watchdog fined Storia Foods and Mrs. Bectors' English Oven Rs 1 lakh each and ordered the…
Digital Culture
John Jumper, the AlphaFold co-creator who shared the 2024 Nobel Prize in Chemistry, said on June 20, 2026…
Science And Wellbeing
Health officials in Maryland, Virginia, and Washington, D.C., issued overlapping measles alerts tied to Washington Dulles International Airport…
Screen And Sound
LACMA's June 20, 2026 Art Parade turned Wilshire Boulevard into a public stage for the David Geffen Galleries…
Fixtures And Form
Tadej Pogacar closed the 2026 Tour de Suisse on June 21 with another stage win, a 6:32 overall…